Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / SPONSORED ADR
-
Total 13F shares
-
7,711,763
-
Share change
-
+680,627
-
Total reported value
-
$8,867,000
-
Price per share
-
$1.15
-
Number of holders
-
24
-
Value change
-
+$948,288
-
Number of buys
-
11
-
Number of sells
-
7
Institutional Holders of BIOLINERX LTD - SPONSORED ADR (BLRX) as of Q3 2016
As of 30 Sep 2016,
BIOLINERX LTD - SPONSORED ADR (BLRX) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,711,763 shares.
The largest 10 holders included
Senvest Management, LLC, ORBIMED ADVISORS LLC, Alyeska Investment Group, L.P., MORGAN STANLEY, Opaleye Management Inc., DEUTSCHE BANK AG\, KCG Holdings, Inc., MENTA CAPITAL LLC, NEXT Financial Group, Inc, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
24
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.